Remove companies puma-biotechnology-inc
article thumbnail

Puma Biotech Investors Ink $54M Deal Over Drug Statements

Law 360

Investors alleging that Puma Biotechnology Inc. misstated the effectiveness of a breast cancer treatment, causing the biopharmaceutical company's share price to drop, asked a California federal judge Monday to preliminarily approve a $54.2

40